10.1074/jbc.M511635200 J
By bridging rigorous mechanistic insights with real-world therapeutic applications, we aim to underscore how a deep understanding of GLP-1 biologyspanning metabolic, cardiovascular, inflammatory, and neurohormonal pathwayscan inform more precise, effective, and individualized treatment strategies
Cell 187, 48334858
4,5,6 Since 2008, the Food and Drug Administration (FDA) and European Medicines Agency have required that new T2D pharmacotherapies undergo rigorous cardiovascular safety clinical trials using hard cardiovascular endpoints and more stringent statistical review
Studies speak clearly After 24 weeks of GlyNAC supplementation, study participants experienced improvements in muscle strength, walking speed, cognitive function, and reduced body fat
But modern stressorspoor diet, chronic inflammation, environmental toxins, injuriesoften overwhelm that innate ability